Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly.
Ruiz S, Gil J, Biagetti B, Venegas E, Cámara R, Garcia-Centeno R, Gálvez MÁ, Picó A, Maraver S, González I, Abellán P, Trincado P, Herrera M, Olvera P, Xifra G, Bernabeu I, Serra-Soler G, Azriel S, García L, Carvalho D, Jordà M, Valassi E, Puig J, Puig-Domingo M.
Ruiz S, et al.
Clin Endocrinol (Oxf). 2023 Oct;99(4):378-385. doi: 10.1111/cen.14946. Epub 2023 Jul 8.
Clin Endocrinol (Oxf). 2023.
PMID: 37421211
Insulin-like growth factor (IGF-I), growth hormone (GH) and tumour volume reduction were assessed after 6 and 12 months of treatment and its effectiveness evaluated according to baseline MRI signal. Hormonal response was considered 'complete' when normalization of IGF-I le …
Insulin-like growth factor (IGF-I), growth hormone (GH) and tumour volume reduction were assessed after 6 and 12 months of treatment and its …